Allogene Therapeutics, Inc. (ALLO)
Allogene Therapeutics, Inc. (ALLO) has reported earnings 21 times since May 05, 2021. The stock moves an average of ±6.06% the day after reporting, closing higher 61.9% of the time. Its largest post-earnings gain was +17.85% (Nov 02, 2023) and its largest decline was -15.93% (May 13, 2025). The next earnings report is predicted for 2026-08-10 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±6.06%
Positive %
61.9%
Negative %
38.1%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 13, 2026 | ☽ POST | $2.28 | $2.35 | $2.33 | 358,322 | -7.31% | open_in_new |
| Mar 12, 2026 | ☽ POST | $2.56 | $2.58 | $2.47 | 3,275,300 | -2.83% | open_in_new |
| Nov 06, 2025 | ☽ POST | $1.11 | $1.11 | $1.05 | 2,716,300 | +12.38% | open_in_new |
| Aug 13, 2025 | ☽ POST | $1.06 | $1.08 | $1.04 | 8,033,900 | +2.88% | open_in_new |
| May 13, 2025 | ☽ POST | $1.20 | $1.20 | $1.13 | 7,336,600 | -15.93% | open_in_new |
| Mar 13, 2025 | ☽ POST | $2.04 | $2.09 | $1.89 | 2,008,400 | +2.65% | open_in_new |
| Nov 07, 2024 | ☽ POST | $3.26 | $3.36 | $3.19 | 2,516,000 | -3.45% | open_in_new |
| Aug 07, 2024 | ☽ POST | $2.61 | $2.71 | $2.47 | 2,479,300 | -4.45% | open_in_new |
| May 13, 2024 | ☽ POST | $2.79 | $2.95 | $2.90 | 1,163,400 | +2.07% | open_in_new |
| Mar 14, 2024 | ☽ POST | $4.80 | $4.85 | $4.50 | 4,026,800 | +3.56% | open_in_new |
| Nov 02, 2023 | ☽ POST | $2.88 | $3.01 | $2.97 | 1,512,500 | +17.85% | open_in_new |
| Aug 02, 2023 | ☽ POST | $4.75 | $4.80 | $4.69 | 2,699,400 | +9.59% | open_in_new |
| May 03, 2023 | ☽ POST | $5.37 | $5.84 | $5.72 | 2,559,400 | +12.76% | open_in_new |
| Feb 28, 2023 | ☽ POST | $6.36 | $6.58 | $6.35 | 1,776,600 | -0.16% | open_in_new |
| Nov 02, 2022 | ☽ POST | $10.57 | $10.81 | $10.17 | 909,400 | -6.39% | open_in_new |
| Aug 09, 2022 | ☽ POST | $15.64 | $16.04 | $15.03 | 1,843,300 | +7.78% | open_in_new |
| May 04, 2022 | ☽ POST | $8.93 | $9.49 | $9.43 | 1,508,300 | -1.91% | open_in_new |
| Feb 23, 2022 | ☽ POST | $9.79 | $10.08 | $9.17 | 1,178,200 | +0.87% | open_in_new |
| Nov 04, 2021 | ☽ POST | $20.16 | $20.27 | $19.43 | 1,921,400 | +3.65% | open_in_new |
| Aug 04, 2021 | ☽ POST | $21.60 | $22.93 | $22.13 | 755,400 | +7.23% | open_in_new |
| May 05, 2021 | ☽ POST | $29.87 | $29.95 | $28.71 | 502,800 | +1.6% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±6.06%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260528 | open_in_new SEC.gov |
| DEFA14A | 20260528 | open_in_new SEC.gov |
| DEFA14A | 20260521 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| 10-Q | 20260513 | open_in_new SEC.gov |
| 8-K | 20260513 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260513 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260513 | open_in_new SEC.gov |
| ARS | 20260430 | open_in_new SEC.gov |
Frequently asked about ALLO earnings
When does Allogene Therapeutics, Inc. report earnings next? expand_more
Allogene Therapeutics, Inc. (ALLO)'s next earnings date is approximate for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does ALLO stock move after earnings? expand_more
Over 21 reports, ALLO has moved an average of ±6.06% the session after earnings, closing higher 61.9% of the time.
What was ALLO's biggest post-earnings move? expand_more
ALLO's largest post-earnings gain on record was +17.85% on Nov 02, 2023, and its largest decline was -15.93% on May 13, 2025.
Where can I find Allogene Therapeutics, Inc.'s SEC filings? expand_more
All of Allogene Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right